Source: Journal of Clinical Investigation
Date: February 3, 2007
Summary:
Although treatment regimens involving the infusion of tumor-reactive T cells into patients with skin cancer (melanoma) have shown clinical benefit, there is plenty of room to improve the protocols to increase therapeutic benefit.
No comments:
Post a Comment